Exclusive

Publication

Byline

Location

US Patent Issued to LG DISPLAY, LT MATERIALS on April 7 for "Heterocyclic compound, organic light emitting device including the same and composition for organic layer of organic light emitting device" (South Korean Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,257, issued on April 7, was assigned to LG DISPLAY Co. LTD. (Seoul, South Korea) and LT MATERIALS Co. LTD. (Yongin-si, South Korea). "Heter... Read More


US Patent Issued to Tolremo Therapeutics on April 7 for "Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer" (Swiss Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,258, issued on April 7, was assigned to Tolremo Therapeutics AG (Muttenz, Switzerland). "Heterocyclic derivatives, pharmaceutical compositi... Read More


US Patent Issued to ZHUHAI UNITED LABORATORIES on April 7 for "Aminopyridine compound" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,259, issued on April 7, was assigned to ZHUHAI UNITED LABORATORIES Co. LTD. (Guangdong, China). "Aminopyridine compound" was invented by Pe... Read More


US Patent Issued to RISEN (SUZHOU) PHARMA TECH, SHANGHAI JUNSHI BIOSCIENCES on April 7 for "Stable heavy isotopes in amide functional groups and uses thereof" (Chinese, Canadian Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,260, issued on April 7, was assigned to RISEN (SUZHOU) PHARMA TECH Co. LTD. (Suzhou, China) and SHANGHAI JUNSHI BIOSCIENCES Co. LTD. (Shangh... Read More


US Patent Issued to BEIJING TIDE PHARMACEUTICAL on April 7 for "P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition containing same, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,261, issued on April 7, was assigned to BEIJING TIDE PHARMACEUTICAL Co. LTD. (Beijing). "P2X3 and/or P2X2/3 receptor antagonist, pharmaceut... Read More


US Patent Issued to Merck Sharp & Dohme on April 7 for "PRMT5 inhibitors" (Canadian, American Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,262, issued on April 7, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.). "PRMT5 inhibitors" was invented by Michelle Machacek (Bosto... Read More


US Patent Issued to BEIJING TIDE PHARMACEUTICAL on April 7 for "Pyrazolopyrimidine compound used as ATR kinase inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,263, issued on April 7, was assigned to BEIJING TIDE PHARMACEUTICAL Co. LTD. (Beijing). "Pyrazolopyrimidine compound used as ATR kinase inh... Read More


US Patent Issued to Gasherbrum Bio on April 7 for "Heterocyclic GLP-1 agonists" (Chinese, American Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,264, issued on April 7, was assigned to Gasherbrum Bio Inc. (South San Francisco, Calif.). "Heterocyclic GLP-1 agonists" was invented by Qi... Read More


US Patent Issued to Blueprint Medicines on April 7 for "Inhibitors of activin receptor-like kinase" (Massachusetts Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,265, issued on April 7, was assigned to Blueprint Medicines Corp. (Cambridge, Mass.). "Inhibitors of activin receptor-like kinase" was inve... Read More


US Patent Issued to SYNGENTA CROP PROTECTION on April 7 for "Pesticidally active heterocyclic derivatives with sulfur containing substituents" (Swiss, British, Indian Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,266, issued on April 7, was assigned to SYNGENTA CROP PROTECTION AG (Basel, Switzerland). "Pesticidally active heterocyclic derivatives wit... Read More